# Evaluation of the Effects of Colipral on Microbiota Gut Composition in Patients Presenting With Ulcerative Colitis During Remission Phase and Functional Disorders

> **NCT07751081** · NA · NOT_YET_RECRUITING · sponsor: **University of Padova** · enrollment: 50 (estimated)

## Conditions studied

- Inflammatory Bowel Disease, Ulcerative Colitis Type
- Functional Disorder of Gastrointestinal Tract

## Interventions

- **DIETARY_SUPPLEMENT:** Food Supplement Colipral in film-coated tablets containing Escherichia coli 5C LMG S-33222
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07751081
- **Lead sponsor:** University of Padova
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-03
- **Final completion:** 2028-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07751081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07751081, "Evaluation of the Effects of Colipral on Microbiota Gut Composition in Patients Presenting With Ulcerative Colitis During Remission Phase and Functional Disorders". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07751081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*